Judy Lieberman has been chosen for the 2023 ICIS-Pfizer Award for Excellence in Cytokine & Interferon Research (formerly the Seymour & Vivian Milstein Award from 1988 – 2020)
Judy Lieberman has been chosen for the 2023 ICIS-Pfizer Award for Excellence in Cytokine & Interferon Research in recognition of her outstanding discoveries in the field of cytokine biology, applying advances in basic science for understanding, treating and preventing human diseases through her studies on the molecular basis of killing by cytotoxic lymphocytes and pyroptotic cell death by GSDMs, the interplay between cytotoxic lymphocytes and GSDMs, and their joint roles in controlling infection and cancer.
